Consecutive lynestrenol and cross-sex hormone treatment in biological female adolescents with gender dysphoria: a retrospective analysis

[1]  S. Alalaf,et al.  Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria , 2016, Archives of Gynecology and Obstetrics.

[2]  Zowie Davy.  The DSM-5 and the Politics of Diagnosing Transpeople , 2015, Archives of sexual behavior.

[3]  P. Cohen-Kettenis,et al.  Adolescents with gender dysphoria. , 2015, Best practice & research. Clinical endocrinology & metabolism.

[4]  B. Kreukels,et al.  Antimüllerian hormone levels decrease in female-to-male transsexuals using testosterone as cross-sex therapy. , 2015, Fertility and sterility.

[5]  A. Heijboer,et al.  Bone mass in young adulthood following gonadotropin-releasing hormone analog treatment and cross-sex hormone treatment in adolescents with gender dysphoria. , 2015, The Journal of clinical endocrinology and metabolism.

[6]  B. Kreukels,et al.  (Patho)physiology of cross‐sex hormone administration to transsexual people: the potential impact of male–female genetic differences , 2015, Andrologia.

[7]  J. Kaufman,et al.  Body composition, bone turnover, and bone mass in trans men during testosterone treatment: 1-year follow-up data from a prospective case-controlled study (ENIGI). , 2014, European journal of endocrinology.

[8]  D. McMahon,et al.  Anti-Mullerian hormone may be a useful adjunct in the diagnosis of polycystic ovary syndrome in nonobese adolescents , 2014, Journal of pediatric endocrinology & metabolism : JPEM.

[9]  J. Kaufman,et al.  Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence. , 2014, The journal of sexual medicine.

[10]  M. Järvelin,et al.  Anti-Müllerian hormone: correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study , 2014, Human reproduction.

[11]  A. Schindler.  The “newer” progestogens and postmenopausal hormone therapy (HRT) , 2014, The Journal of Steroid Biochemistry and Molecular Biology.

[12]  L. Gooren.  Management of female-to-male transgender persons: medical and surgical management, life expectancy , 2014, Current opinion in endocrinology, diabetes, and obesity.

[13]  E. Giltay,et al.  Cardiovascular disease in transsexual persons treated with cross-sex hormones: reversal of the traditional sex difference in cardiovascular disease pattern. , 2014, European journal of endocrinology.

[14]  D. Metzger,et al.  Clinical management of youth with gender dysphoria in Vancouver. , 2014, The Journal of pediatrics.

[15]  J. Kaufman,et al.  Short- and long-term clinical skin effects of testosterone treatment in trans men. , 2014, The journal of sexual medicine.

[16]  W. Hembree.  Management of juvenile gender dysphoria , 2013, Current opinion in endocrinology, diabetes, and obesity.

[17]  Tsuyoshi Saito,et al.  Excessive androgen exposure in female-to-male transsexual persons of reproductive age induces hyperplasia of the ovarian cortex and stroma but not polycystic ovary morphology. , 2013, Human reproduction.

[18]  Lina Al-Imari,et al.  The safety of testosterone therapy in women. , 2012, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[19]  J. Kaufman,et al.  Bone mass, bone geometry, and body composition in female-to-male transsexual persons after long-term cross-sex hormonal therapy. , 2012, The Journal of clinical endocrinology and metabolism.

[20]  B. Kreukels,et al.  Puberty suppression in gender identity disorder: the Amsterdam experience , 2011, Nature Reviews Endocrinology.

[21]  L. Gooren.  Clinical practice. Care of transsexual persons. , 2011, The New England journal of medicine.

[22]  S. Kurtoğlu,et al.  Insulin Resistance in Obese Children and Adolescents: HOMA−IR Cut−Off Levels in the Prepubertal and Pubertal Periods , 2010, Journal of clinical research in pediatric endocrinology.

[23]  R. Fanchin,et al.  Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population. , 2010, Reproductive biomedicine online.

[24]  P. Cohen-Kettenis,et al.  The DSM Diagnostic Criteria for Gender Identity Disorder in Adolescents and Adults , 2010, Archives of sexual behavior.

[25]  G. T’Sjoen,et al.  The endocrine treatment of transsexual adolescents , 2010 .

[26]  M. Roelants,et al.  References for growth and pubertal development from birth to 21 years in Flanders, Belgium , 2009, Annals of human biology.

[27]  V. Montori,et al.  Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. , 2009, The Journal of clinical endocrinology and metabolism.

[28]  P. Cohen-Kettenis,et al.  Psychosexual outcome of gender-dysphoric children. , 2008, Journal of the American Academy of Child and Adolescent Psychiatry.

[29]  L. Gooren,et al.  Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones. , 2008, European journal of endocrinology.

[30]  H. Delemarre-van de Waal,et al.  The treatment of adolescent transsexuals: changing insights. , 2008, The journal of sexual medicine.

[31]  I. Heilberg,et al.  Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[32]  J. Nascimento,et al.  Chronic administration of anabolic androgenic steroid alters murine thyroid function. , 2006, Medicine and science in sports and exercise.

[33]  N. Chau,et al.  Associations of family environment and individual factors with tobacco, alcohol and illicit drug use in adolescents , 2004, European Journal of Epidemiology.

[34]  Harm Kuipers,et al.  Effects of Androgenic-Anabolic Steroids in Athletes , 2004, Sports medicine.

[35]  C. Campagnoli,et al.  Classification and pharmacology of progestins. , 2003, Maturitas.

[36]  D. Rubinow,et al.  Neuroendocrine and behavioral effects of high-dose anabolic steroid administration in male normal volunteers , 2003, Psychoneuroendocrinology.

[37]  W. Bukowski,et al.  Is Gender Identity Disorder in Children a Mental Disorder? , 2000 .

[38]  S. Ratnam,et al.  Effect of Implanon use on selected parameters of thyroid and adrenal function. , 2000, Contraception.

[39]  D. Paulus,et al.  Smoking during adolescence , 2000 .

[40]  S. H. Goozen,et al.  Pubertal delay as an aid in diagnosis and treatment of a transsexual adolescent , 1998, European Child & Adolescent Psychiatry.

[41]  C. Bondy,et al.  Androgens stimulate early stages of follicular growth in the primate ovary. , 1998, The Journal of clinical investigation.

[42]  P. Darney.  The androgenicity of progestins. , 1995, The American journal of medicine.

[43]  S. Ratnam,et al.  The impact of long-term testosterone replacement therapy on lipid and lipoprotein profiles in women. , 1995, Maturitas.

[44]  C. Gluud,et al.  Liver pathology associated with the use of anabolic-androgenic steroids. , 2008, Liver.

[45]  M. Rudnick,et al.  A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis. , 1992, Clinical nephrology.

[46]  J. Roberts,et al.  Maintenance Immunosuppression After Liver Transplantation , 1992, Seminars in liver disease.

[47]  P. Hompes,et al.  Effects of long-term testosterone administration on gonadotropin secretion in agonadal female to male transsexuals compared with hypogonadal and normal women. , 1989, The Journal of clinical endocrinology and metabolism.

[48]  P. Demacker,et al.  Deleterious Effects of Anabolic Steroids on Serum Lipoproteins, Blood Pressure, and Liver Function in Amateur Body Builders , 1988, International journal of sports medicine.

[49]  W. Futterweit,et al.  Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals. , 1986, The Journal of clinical endocrinology and metabolism.

[50]  A. Ruokonen,et al.  Effects of desogestrel, levonorgestrel and lynestrenol on serum sex hormone binding globulin, cortisol binding globulin, ceruloplasmin and HDL-cholesterol. , 1985, European journal of obstetrics, gynecology, and reproductive biology.

[51]  M. Alen,et al.  Androgenic steroid effects on liver and red cells. , 1985, British Journal of Sports Medicine.

[52]  K. Ishak.  Hepatic Lesions Caused by Anabolic and Contraceptive Steroids 1 , 1981, Seminars in liver disease.

[53]  P. Beck.  EFFECT OF PROGESTINS ON GLUCOSE AND LIPID METABOLISM * , 1977, Annals of the New York Academy of Sciences.

[54]  A. Banks,et al.  Anabolic steroids in athelics: crossover double-blind trial on weightlifters. , 1975, British medical journal.

[55]  P. Beck.  Contraceptive steroids: modifications of carbohydrate and lipid metabolism. , 1973, Metabolism: clinical and experimental.